Boniva and Diplopia - a phase IV clinical study of FDA data

Summary:

Diplopia is reported as a side effect among people who take Boniva (ibandronate sodium), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Fosamax, and have Multiple sclerosis.

The phase IV clinical study analyzes which people have Diplopia when taking Boniva. It is created by eHealthMe based on reports of 26,949 people who have side effects when taking Boniva from the FDA, and is updated regularly.

What is Boniva?

Boniva has active ingredients of ibandronate sodium. It is often used in osteoporosis. eHealthMe is studying from 27,340 Boniva users. Check the latest studies of Boniva.

What is Diplopia?

Diplopia (double vision) is found to be associated with 1,438 drugs and 1,892 conditions by eHealthMe. Check the latest studies of Diplopia.

On Jul, 08, 2026

26,949 people reported to have side effects when taking Boniva.
Among them, 44 people (0.16%) have Diplopia.

Among these 44 people:

How long have people been on Boniva when they have Diplopia? *

What is the gender of people who have Diplopia when taking Boniva? *

female: 90.7 %
male: 9.3 %

What is the age of people who have Diplopia when taking Boniva? *

What are other drugs people take besides Boniva? *

What are other side effects people have besides Diplopia? *

Dizziness: 26 people, 59.09%
Vision Blurred: 23 people, 52.27%
Weakness: 22 people, 50.00%
Depression: 21 people, 47.73%
Headache (pain in head): 19 people, 43.18%
Urinary Incontinence (inability to control the flow of urine and involuntary urination): 17 people, 38.64%
Dyspnea (difficult or laboured breathing): 16 people, 36.36%
Fall: 15 people, 34.09%
Joint Pain: 15 people, 34.09%
Back Pain: 14 people, 31.82%

What are the existing conditions these people have? *

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 7 people, 15.91%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 11.36%
Breast Cancer: 4 people, 9.09%
High Blood Pressure: 3 people, 6.82%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 6.82%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 3 people, 6.82%
Skin Wrinkling (wrinkle on skin): 2 people, 4.55%
Bone Density Decreased: 2 people, 4.55%
High Blood Cholesterol: 2 people, 4.55%
Myasthenia Gravis (a chronic condition that causes muscles to tire and weaken easily): 2 people, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Boniva and have Diplopia?

- Check whether Diplopia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Boniva:

Boniva (27,340 reports)

Diplopia treatments and more:

Diplopia (32,465 reports)

Browse all side effects of Boniva:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Diplopia:

Diplopia (1,438 drugs)

Browse all the conditions that are associated with Diplopia:

Diplopia (1,892 conditions)

Related publications that referenced our studies

Kocamaz, M., & Karadag, O., "Topiramate-Induced Acute Myopia, Diplopia, and Photosensitivity: A Case Report", Beyoglu Eye Journal, 2019 Jan .
Kocamaz, M., & Karadag, O., "Topiramate-Induced Acute Myopia, Diplopia, and Photosensitivity: A Case Report", Beyoglu Eye Journal, 2019 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on ibandronate sodium (the active ingredients of Boniva) and Boniva (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.